Tweeter button Delicious button Digg button Stumbleupon button
Monthly Archives: February 2014
Cirrhosis | Hyperion Therapeutics Announces The Publication Of Phase 2 Results Of Glycerol Phenylbutyrate (GPB) For The Treatment …

About Hepatic Encephalopathy HE is a serious but potentially reversible neurological disorder that can occur in patients with cirrhosis of any etiology or acute liver failure. HE comprises a spectrum of neurological signs and symptoms ranging from mild (e.g. minimal disorientation) to severe (e.g. coma, death) and is believed to occur when the brain is exposed to gut-derived toxins such as    .. more …

Facebook Twitter Email

Posted on February 25, 2014, 8:36 pm By
Categories: cirrhosis Tags:
Liver Diseases | Glycerol Phenylbutyrate Reduces Hepatic Encephalopathy Events

PUBLIC RELEASE DATE: 25-Feb-2014 Contact: Dawn Peters sciencenewsroom@wiley.com 781-388-8408 Wiley Glycerol phenylbutyrate reduces hepatic encephalopathy events And ammonia levels compared to placebo Phase 2 trial results published in the March issue of Hepatology , a journal of the American Association for the Study of Liver Diseases, suggests the potential for Glycerol Phenylbutyrate (GPB) to    .. more …

Facebook Twitter Email

Important Disclaimer: Article Comments provided are for general information purposes only and are not intended to substitute for informed professional medical, psychological, tax, accounting, legal, investment, or any other professional advice. We expressly disclaim liability for any product, manufacturer, distributor, service or service provider mentioned or any opinion expressed in these comments or anywhere else within the site. Lastly, we do not endorse any article or comment. Use at your own risk.